Ledger.Open graph →
SEC Form D · filed November 21, 2022

Cue Biopharma, Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Tamar G. Howson · Boston, MADirectorDaniel R. Passeri · Boston, MAExec · DirectorFrank G. Morich · Boston, MADirectorAaron G. Fletcher · Boston, MADirectorPeter A. Kiener · Montecito, CADirectorKerri-Ann R. Millar · Boston, MAExecAnish R. Suri · Boston, MAExecFrederick G. Driscoll · Boston, MADirectorPatricia R. Nasshorn · Boston, MAExecColin G. Sandercock · Boston, MAExecKen R. Pienta · Boston, MAExecTamar G. Howson · Boston, MADirectorDaniel R. Passeri · Lexington, MAExec · DirectorAaron G. Fletcher · Boston, MADirectorPeter A. Kiener · Montecito, CADirectorKerri-Ann R. Millar · Boston, MAExecAnish R. Suri · Boston, MAExecFrank G. Morich · Boston, MADirectorFrederick G. Driscoll · Boston, MADirectorPatricia R. Nasshorn · Boston, MAExecColin G. Sandercock · Boston, MAExecKen R. Pienta · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗